Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/23/2025 | $135.00 | Buy | Jefferies |
| 10/27/2023 | $47.00 → $55.00 | Neutral → Outperform | Robert W. Baird |
| 7/7/2023 | $44.00 | Market Perform → Outperform | BMO Capital Markets |
| 8/23/2021 | $40.00 | Market Perform | BMO Capital Markets |
4 - Adtalem Global Education Inc. (0000730464) (Issuer)
4 - Adtalem Global Education Inc. (0000730464) (Issuer)
4 - Adtalem Global Education Inc. (0000730464) (Issuer)
Jefferies initiated coverage of Adtalem Global Education with a rating of Buy and set a new price target of $135.00
Robert W. Baird upgraded Adtalem Global Education from Neutral to Outperform and set a new price target of $55.00 from $47.00 previously
BMO Capital Markets upgraded Adtalem Global Education from Market Perform to Outperform and set a new price target of $44.00
4 - Adtalem Global Education Inc. (0000730464) (Issuer)
4 - Adtalem Global Education Inc. (0000730464) (Issuer)
4 - Adtalem Global Education Inc. (0000730464) (Issuer)
Company Completes Accelerated Share Repurchase Program New Three-Year, $750 Million Authorization Reflects Continued Confidence in Company's Fundamental Strength and Long-Term Strategic Outlook Adtalem Global Education Inc. (NYSE:ATGE), America's largest healthcare educator, today announced the completion of its $150 million share repurchase program, under which the Company repurchased approximately 1.6 million shares, and a new $750 million share repurchase authorization approved by the Board of Directors through December 2028. The new three-year authorization underscores management and the Board's conviction in Adtalem's strategic direction, strong financial position, and ability to gen
Company to Actively Deploy Share Repurchase Authorization Reflecting Confidence in Company's Fundamental Strength Reaffirms Fiscal Year 2026 Outlook Adtalem Global Education Inc. (NYSE:ATGE), the largest healthcare educator in the United States, today announced plans to accelerate execution against its remaining $136 million balance under its existing $150 million board authorized share repurchase program1, reflecting its current financial strength through revenue and profit growth as well as confidence in the Company's long-term outlook. "Adtalem's Board of Directors and management remain confident in the Company's strategic position and long-term outlook. We continue to deliver strong
Total enrollment up 8.0% YoY Revenue up 10.8% YoY Diluted earnings per share $1.67; Adjusted EPS $1.75, growth of 35.7% YoY First quarter highlights Total student enrollment 97,359, up 8.0% year-over-year Revenue $462.3 million, up 10.8% year-over-year Chamberlain University achieved eleventh straight quarter of total enrollment growth, up 2.2% year-over-year Walden University achieved ninth straight quarter of total enrollment growth, up 13.6% year-over-year, highest total enrollment in university history Medical & Veterinary segment achieved third straight enrollment cycle growth, up 2.4% year-over-year Sustaining momentum, GAAP net income $61.8 million; adjusted E
8-K - Adtalem Global Education Inc. (0000730464) (Filer)
8-K - Adtalem Global Education Inc. (0000730464) (Filer)
10-Q - Adtalem Global Education Inc. (0000730464) (Filer)
Noel brings two decades of corporate affairs leadership and strategic stakeholder engagement experience Adtalem Global Education (NYSE:ATGE), the leading healthcare educator in the United States, has appointed Megan Noel as its Chief Corporate Affairs Officer, effective immediately. Noel will lead Adtalem's corporate affairs function, overseeing communications, investor relations, government relations, impact and alumni engagement, ensuring the company's stakeholder engagement strategy supports its growth strategy. She will be responsible for driving strategic outcomes across Adtalem's portfolio of institutions while engaging a broad range of stakeholders, including its nearly 10,000 empl
Mary Beth Kingston joins Chamberlain University's Board of Trustees, bringing her visionary leadership and innovative approach to nursing to the nation's largest nursing school. Chamberlain University, an Adtalem Global Education (NYSE:ATGE) institution and largest nursing school in the country1, has appointed Mary Beth Kingston, PhD, RN, FAAN, to its board of trustees as chair, effective immediately. A 2024 recipient of the prestigious Lifetime Achievement Award from the American Organization for Nursing Leadership (AONL), Kingston brings more than 40 years of experience in the healthcare industry to Chamberlain University. A visionary leader in nursing, Mary Beth Kingston brings her inn
Adtalem Global Education (NYSE:ATGE), a national leader in post-secondary education and the nation's largest healthcare educator1, has appointed Sara Hill as Chief Human Resources Officer, effective September 9, 2024. Hill joins Adtalem from Intricon, where she spent the last four years serving as the Chief Human Resources Officer. Intricon is a private equity owned contract development manufacturer of micromedical technologies. During her time at Intricon, she played a key role in developing organizational growth and development strategies that support company culture, brand evolution and business transformation initiatives. "I am absolutely delighted to welcome Sara Hill to the Adtale
Total enrollment up 8.0% YoY Revenue up 10.8% YoY Diluted earnings per share $1.67; Adjusted EPS $1.75, growth of 35.7% YoY First quarter highlights Total student enrollment 97,359, up 8.0% year-over-year Revenue $462.3 million, up 10.8% year-over-year Chamberlain University achieved eleventh straight quarter of total enrollment growth, up 2.2% year-over-year Walden University achieved ninth straight quarter of total enrollment growth, up 13.6% year-over-year, highest total enrollment in university history Medical & Veterinary segment achieved third straight enrollment cycle growth, up 2.4% year-over-year Sustaining momentum, GAAP net income $61.8 million; adjusted E
Adtalem Global Education Inc. (NYSE:ATGE), the largest healthcare educator in the United States, announced today it will release its first quarter fiscal year 2026 results on Thursday, Oct. 30, 2025, after financial markets close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results. The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Adtalem earnings call" or by using conference ID: 13756230. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com. Adtalem will archive a replay of the call for 30 days. To access t
Total enrollment up 10.2% YoY for fourth quarter 2025 Revenue up 12.9% YoY for fiscal 2025 Fiscal 2025 diluted earnings per share $6.18; Adjusted EPS $6.67, growth of 33.1% YoY Fourth quarter highlights Revenue $457.1 million, up 11.5% year-over-year Total student enrollment 91,780, up 10.2% year-over-year Chamberlain tenth straight quarter of total enrollment growth, up 5.8% year-over-year Walden eighth straight quarter of total enrollment growth, up 15.0% year-over-year Medical and Veterinary sustained total enrollment growth, up 1.0% year-over-year GAAP net income $54.2 million; adjusted EBITDA $110.2 million, up 13.2% year-over-year Fiscal year highlights R
SC 13G/A - Adtalem Global Education Inc. (0000730464) (Subject)
SC 13G - Adtalem Global Education Inc. (0000730464) (Subject)
SC 13G/A - Adtalem Global Education Inc. (0000730464) (Subject)